» Articles » PMID: 15542429

Ras-induced Interleukin-8 Expression Plays a Critical Role in Tumor Growth and Angiogenesis

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2004 Nov 16
PMID 15542429
Citations 371
Authors
Affiliations
Soon will be listed here.
Abstract

The role of Ras oncogenes in promoting cellular transformation is well established. However, the contribution of Ras signaling to interactions between tumor cells and their host environment remains poorly characterized. Here, we demonstrate that the inflammatory mediator interleukin-8 (CXCL-8/IL-8) is a transcriptional target of Ras signaling. Using a tumor xenograft model, we show that Ras-dependent CXCL-8 secretion is required for the initiation of tumor-associated inflammation and neovascularization. Collectively, our data identify a novel mechanism by which the Ras oncogene can elicit a stromal response that fosters cancer progression.

Citing Articles

Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies.

Hussain M, Goyal A, Goyal K, S R, Nellore J, Shahwan M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40047857 DOI: 10.1007/s00210-025-03970-x.


Inflammation in cancer: therapeutic opportunities from new insights.

Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q Mol Cancer. 2025; 24(1):51.

PMID: 39994787 PMC: 11849313. DOI: 10.1186/s12943-025-02243-8.


Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach.

Kawashima J, Endo Y, Rashid Z, Altaf A, Woldesenbet S, Tsilimigras D Hepatobiliary Surg Nutr. 2025; 14(1):3-15.

PMID: 39925922 PMC: 11806131. DOI: 10.21037/hbsn-24-385.


Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways.

Seres M, Spacayova K, Sulova Z, Spaldova J, Breier A, Pavlikova L Cancers (Basel). 2025; 17(2).

PMID: 39858030 PMC: 11763799. DOI: 10.3390/cancers17020248.


Advancements in gene therapies targeting mutant KRAS in cancers.

Wang Y, Bui T, Yang X, Hutvagner G, Deng W Cancer Metastasis Rev. 2025; 44(1):24.

PMID: 39820726 PMC: 11748474. DOI: 10.1007/s10555-025-10243-9.